Shinva Medical Instrument Co Ltd
SSE:600587

Watchlist Manager
Shinva Medical Instrument Co Ltd Logo
Shinva Medical Instrument Co Ltd
SSE:600587
Watchlist
Price: 13.75 CNY 0.36% Market Closed
Market Cap: ¥8.3B

EV/GP

2.8
Current
17%
Cheaper
vs 3-y average of 3.4

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
2.8
=
Enterprise Value
¥7.6B
/
Gross Profit
¥2.3B

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
2.8
=
Enterprise Value
¥7.6B
/
Gross Profit
¥2.3B

Valuation Scenarios

Shinva Medical Instrument Co Ltd is trading below its 3-year average

If EV/GP returns to its 3-Year Average (3.4), the stock would be worth ¥16.62 (21% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+379%
Average Upside
156%
Scenario EV/GP Value Implied Price Upside/Downside
Current Multiple 2.8 ¥13.75
0%
3-Year Average 3.4 ¥16.62
+21%
5-Year Average 3.6 ¥17.61
+28%
Industry Average 8.4 ¥40.77
+197%
Country Average 13.6 ¥65.92
+379%

Forward EV/GP
Today’s price vs future gross profit

Not enough data available to calculate forward EV/GP

Peer Comparison

All Multiples
EV/GP
P/E
All Countries
Close
Market Cap EV/GP P/E
CN
Shinva Medical Instrument Co Ltd
SSE:600587
8.3B CNY 2.8 16.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
162.6B USD 23.6 56.9
US
Abbott Laboratories
NYSE:ABT
155.4B USD 6.1 24.8
US
Stryker Corp
NYSE:SYK
112.7B USD 7.6 34.7
IE
Medtronic PLC
NYSE:MDT
102.7B USD 5.3 22.3
US
Boston Scientific Corp
NYSE:BSX
83.8B USD 6.5 23.5
US
Edwards Lifesciences Corp
NYSE:EW
48.8B USD 9.2 44.5
DE
Siemens Healthineers AG
XETRA:SHL
39.3B EUR 5.2 18.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.2B USD 17.1 42.7
US
Becton Dickinson and Co
NYSE:BDX
42.5B USD 5.8 24.2
US
Resmed Inc
NYSE:RMD
29.9B USD 8.8 20.1

Market Distribution

Lower than 91% of companies in China
Percentile
9th
Based on 6 967 companies
9th percentile
2.8
Low
0 — 8
Typical Range
8 — 23.3
High
23.3 —
Distribution Statistics
China
Min 0
30th Percentile 8
Median 13.6
70th Percentile 23.3
Max 17 898 541.1

Shinva Medical Instrument Co Ltd
Glance View

Market Cap
8.3B CNY
Industry
Health Care

In the brisk hustle of China's healthcare evolution, Shinva Medical Instrument Co., Ltd. stands as a pivotal player, navigating the intricate world of medical devices and pharmaceutical machinery since its inception in 1943. Rooted deeply in the tangible yet transformative realm of healthcare technology, Shinva has advanced from its initial focus on producing pharmaceutical sterilization equipment to a comprehensive provider of medical solutions. With its headquarters in the tech-driven province of Shandong, Shinva operates in various sectors, providing a multifaceted approach to healthcare. The company’s operations span across diverse segments including medical devices, environmental protection equipment, and pharmaceutical engineering services, ensuring it remains adaptive to contemporary medical demands and regulatory standards. Revenue flows primarily from the design, manufacture, and distribution of medical and laboratory equipment, widening its customer base from local hospitals to international healthcare facilities. Shinva’s portfolio is intriguingly broad, encompassing products that range from high-end sterilization tools and radiation therapy equipment to diagnostic imaging and surgical instruments. This diversification safeguards the company against market volatility while aligning with the ever-increasing demand for efficiency and safety in medical procedures. Moreover, its commitment to research and development underscores its strategic mission to innovate and refine healthcare delivery systems, anchoring its status as a leader in the industry. This adaptability and relentless pursuit of quality enable Shinva to thrive, aptly positioning it to grow alongside China's expansive healthcare sector.

Intrinsic Value
27.41 CNY
Undervaluation 50%
Intrinsic Value
Price ¥13.75
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett